EA201200198A1 - Улучшенная система экспрессии длинного пентраксина 3 человека и ее применение - Google Patents

Улучшенная система экспрессии длинного пентраксина 3 человека и ее применение

Info

Publication number
EA201200198A1
EA201200198A1 EA201200198A EA201200198A EA201200198A1 EA 201200198 A1 EA201200198 A1 EA 201200198A1 EA 201200198 A EA201200198 A EA 201200198A EA 201200198 A EA201200198 A EA 201200198A EA 201200198 A1 EA201200198 A1 EA 201200198A1
Authority
EA
Eurasian Patent Office
Prior art keywords
person
expression
long
application
improved system
Prior art date
Application number
EA201200198A
Other languages
English (en)
Other versions
EA023191B1 (ru
Inventor
Марика Сассано
Аделаиде Эспозито
Винченцо Ривеччио
Джованни Кассани
Original Assignee
Текноджен С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Текноджен С.П.А. filed Critical Текноджен С.П.А.
Publication of EA201200198A1 publication Critical patent/EA201200198A1/ru
Publication of EA023191B1 publication Critical patent/EA023191B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к эукариотическому вектору экспрессии, содержащему последовательность нуклеотидов, кодирующую длинный пентраксин РТХ3 человека под контролем эффективного промотора, и последовательность нуклеотидов, кодирующую селектируемый маркер, к рекомбинантной клетке человека, способной экспрессировать белки, кодируемые указанным вектором, и к способам получения длинного пентраксина РТХ3 человека.
EA201200198A 2009-07-29 2010-07-20 Рекомбинантная клетка человека, способная экспрессировать белок длинного пентраксина ptx3 человека, и ее применение EA023191B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166759 2009-07-29
PCT/EP2010/060469 WO2011012496A1 (en) 2009-07-29 2010-07-20 Improved human long pentraxin 3 expression system and uses thereof

Publications (2)

Publication Number Publication Date
EA201200198A1 true EA201200198A1 (ru) 2012-06-29
EA023191B1 EA023191B1 (ru) 2016-05-31

Family

ID=41120115

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200198A EA023191B1 (ru) 2009-07-29 2010-07-20 Рекомбинантная клетка человека, способная экспрессировать белок длинного пентраксина ptx3 человека, и ее применение

Country Status (23)

Country Link
US (1) US8883446B2 (ru)
EP (1) EP2459721B1 (ru)
JP (1) JP5859963B2 (ru)
KR (1) KR101767695B1 (ru)
CN (1) CN102549160B (ru)
AU (1) AU2010277786B2 (ru)
BR (1) BR112012001980A2 (ru)
CA (1) CA2769257C (ru)
CY (1) CY1116486T1 (ru)
DK (1) DK2459721T3 (ru)
EA (1) EA023191B1 (ru)
ES (1) ES2432242T3 (ru)
HK (1) HK1172649A1 (ru)
HR (1) HRP20130947T1 (ru)
IL (1) IL217696A (ru)
ME (1) ME01566B (ru)
MX (1) MX2012001109A (ru)
PL (1) PL2459721T3 (ru)
PT (1) PT2459721E (ru)
RS (1) RS53006B (ru)
SG (1) SG177756A1 (ru)
SI (1) SI2459721T1 (ru)
WO (1) WO2011012496A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206433B2 (en) * 2013-05-01 2015-12-08 Dna Twopointo, Inc. Methods, compositions and kits for a one-step DNA cloning system
US10253321B2 (en) 2013-05-01 2019-04-09 Dna2.0, Inc. Methods, compositions and kits for a one-step DNA cloning system
TWI528969B (zh) * 2013-06-07 2016-04-11 國立成功大學 胺基酸序列用於製備抑制ｐｔｘ３治療鼻咽癌之醫藥組合物之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
EP2311962B1 (en) * 2002-03-29 2013-03-13 XOMA Technology Ltd. Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
WO2009095403A1 (en) * 2008-01-29 2009-08-06 Tecnogen S.P.A. Expression system and uses thereof for the production of human long pentraxin 3

Also Published As

Publication number Publication date
US8883446B2 (en) 2014-11-11
CA2769257A1 (en) 2011-02-03
AU2010277786B2 (en) 2016-04-14
WO2011012496A1 (en) 2011-02-03
CY1116486T1 (el) 2017-03-15
EP2459721A1 (en) 2012-06-06
HK1172649A1 (en) 2013-04-26
JP2013504304A (ja) 2013-02-07
DK2459721T3 (da) 2013-11-04
ES2432242T3 (es) 2013-12-02
MX2012001109A (es) 2012-03-26
EP2459721B1 (en) 2013-09-18
EA023191B1 (ru) 2016-05-31
PL2459721T3 (pl) 2014-01-31
HRP20130947T1 (hr) 2013-11-08
SI2459721T1 (sl) 2013-11-29
IL217696A (en) 2017-06-29
CN102549160A (zh) 2012-07-04
KR101767695B1 (ko) 2017-08-11
CA2769257C (en) 2017-12-05
CN102549160B (zh) 2014-04-02
RS53006B (en) 2014-04-30
SG177756A1 (en) 2012-02-28
ME01566B (me) 2014-09-20
US20120301873A1 (en) 2012-11-29
BR112012001980A2 (pt) 2015-09-01
JP5859963B2 (ja) 2016-02-16
AU2010277786A1 (en) 2012-03-01
PT2459721E (pt) 2013-10-31
KR20120047259A (ko) 2012-05-11

Similar Documents

Publication Publication Date Title
PH12019500694A1 (en) Factor viii compositions and methods of making and using the same
NZ585190A (en) Engineered dendritic cells and uses for the treatment of cancer
MX346923B (es) Genes y proteinas para sintesis de alcanoil-coa.
BR112017009177A2 (pt) vacinas terapêuticas contra hpv16
CL2013000475A1 (es) Polipeptidos de relaxina que comprende uno o mas aminoacidos codificados no naturales; acido nucleico aislado; metodo para preparar el polipeptido de relaxina.
JP2009261399A5 (ru)
EA201190326A8 (ru) Полипептиды гормона роста и способы их получения и применения
EP4223772A3 (en) Optimized factor viii gene
MX2014001383A (es) Colageno 7 y metodos relacionados.
MX353499B (es) Sistema de expresion en cho.
EP3130598A3 (en) Expression sequences
MD4548C1 (ru) Полипептиды которые связываются к CX3CR1
PH12015500771A1 (en) Novel fc gamma receptor iib variants
EA201300056A1 (ru) Полипептид с активностью ацетилксиланэстеразы и его применения
BR112016014920A2 (pt) novo anticorpo anti-bdca-2 humano
MX2020002903A (es) Método para potenciar la expresión de arn en una célula.
EA201200198A1 (ru) Улучшенная система экспрессии длинного пентраксина 3 человека и ее применение
MX365560B (es) Proteinas quimericas basadas en cyaa que comprenden un polipeptido heterologo y sus usos en la induccion de respuestas inmunes.
EA201300059A1 (ru) Полипептид, обладающий активностью сволленина, и его применение
IN2013MU02526A (ru)
WO2009011940A3 (en) Microcin h47 plasmid selection system
MX2016002556A (es) Métodos y composiciones para el tratamiento de patologías del tejido de cartílago y disco.
WO2011064437A3 (es) Vectores virales y procedimientos útiles en la preparación de gdnf
EA201590431A1 (ru) Пшеница с новыми аллелями rht-b1
RU2008150348A (ru) ЭКСПРЕССИОННАЯ ПЛАЗМИДНАЯ ДНК pCID-PROC, КОДИРУЮЩАЯ ПРОТЕИН С ЧЕЛОВЕКА, И КЛЕТОЧНАЯ ЛИНИЯ DG-CID-PROC-1, ПРОДУЦИРУЮЩАЯ РЕКОМБИНАНТНЫЙ ПРОТЕИН С ЧЕЛОВЕКА

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ MD TM RU